$0.70
$0.00 (0.00%)
End-of-day quote: 05/31/2024
NasdaqCM:CTXR
Citius Pharmaceuticals Annual Report
| Year | Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | ||
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| EPS | Earnings Per Share |
|
$0.00 | $-0.22 | $-0.23 | $-0.23 | $-0.45 | $-0.77 | $-1.21 | $-1.89 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | ||
| Sha. | Shares |
|
146.21m | 145.98m | 55.58m | 28.93m | 16.2m | 8.35m | ||
| OCF | Operating Cash Flow |
|
$-28.36M | $-24.25M | $-16.93M | $-12.44M | $-11.32M | $-7.97M | ||
| FCF | Free Cash Flow |
|
$0.00M | $-24.26M | $0.00M | $0.00M | $0.00M | $0.00M | ||
| FCFS | Free Cash Flow Per Share |
|
$-0.19 | $-0.59 | $-0.43 | $-0.62 | $-1.05 | $-1.45 |
